Gilead Sciences to Present at the NASDAQ OMX 23rd Investor Program

Webcast Available Through Gilead Corporate Website

FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 24, 2009-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be webcasting its corporate presentation at the NASDAQ OMX 23rd Investor Program in London.

Kevin Young, Gilead’s Executive Vice President of Commercial Operations, will provide an overview of the company at the NASDAQ OMX Investor Program on Tuesday, December 1 at 10:15 a.m. Greenwich Mean Time (5:15 a.m. EST).

To access the live webcast or a replay via the internet log on to www.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations